Complications of Apheresis

Seminars in Dialysis

Volumn 25, Issue 2, 2012, Pages 152-158

  Kaplan, Andre A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLAXIS; APHERESIS; ARTICLE; BACTERIAL INFECTION; BLOOD CLOTTING DISORDER; FEMALE; HOSPITALIZATION; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPOTENSION; LUNG INJURY; MALE; METHODOLOGY; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; VIRUS INFECTION;

ANAPHYLAXIS; BACTERIAL INFECTIONS; BLOOD COAGULATION DISORDERS; BLOOD COMPONENT REMOVAL; FEMALE; HUMANS; HYPOCALCEMIA; HYPOKALEMIA; HYPOTENSION; LUNG INJURY; MALE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; VIRUS DISEASES;

EID: 84858709229     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.01026.x     Document Type: Article

References (86)

1. Isbister JP: The risk/benefit equation for therapeutic plasma exchange. Nydegger UE (ed.). Therapeutic Hemapheresis in the 1990s. Basel, Switzerland: Karger AG, 1990:10-30
2. Hazards of apheresis (editorial). Lancet 2:1025-1026, 1982
3. Westphal RG: Complications of hemapheresis. Westphal RG, Kasprisin DO (eds). Current Status of Hemapheresis: Indications, Technology and Complications. Arlington, VA: American Association of Blood Banks, 1987:87-104
4. Borberg H: Problems of plasma exchange therapy. Gurland HJ, Heinze V, Lee HA (eds). Therapeutic Plasma Exchange. New York, NY: Springer-Verlag, 1980:191-201
5. Aufeuvre JP, Morin-Hertel F, Cohen-Solal M, Lefloch A, Baudelot J: Hazards of plasma exchange. Sieberth HG (ed.). Plasma Exchange. Stuttgart, Germany: FK Schattauer Verlag, 1980:149-157
6. Ziselman EM, Bongiovanni MB, Wurzel HA: The complications of therapeutic plasma exchange. Vox Sang 46:270-276, 1984
7. Fabre M, Andreu G, Mannoni P: Some biological modifications and clinical hazards observed during plasma exchanges. Seiberth HG (ed.). Plasma Exchange. Stuttgart, Germany: FK Schattauer Verlag, 1980:143-148
8. Rossi PL, Cecchini L, Minichella G, De Rosa G, Alfano G, Pieralla L, Testa A, Candido A, Vittorio M, Mango G: Comparison of the side effects of therapeutic cytapheresis and those of other types of hemapheresis. Haematologica 76(Suppl 1):75-80, 1991
9. Sprenger KBG, Rasche H, Franz HE: Membrane plasma separation: complications and monitoring. Artif Organs 8:360-363, 1984
10. Samtleben W, Hillebrand G, Krumme D, Gurland HJ: Membrane plasma separation: clinical experience with more than 120 plasma exchanges. Sieverth HG (ed.). Plasma Exchange. Stuttgart, Germany: FK Schattauer Verlag, 1980:23-27
11. Sutton DMC, Nair RC, Rock G, the Canadian Apheresis Study Group: Complications of plasma exchange. Transfusion 29:124-127, 1989
12. Mokrzycki M, Kaplan AA: Therapeutic plasma exchange: complications and management. Am J Kidney Dis 23:817-827, 1994
13. Okafor C, Ward DM, Mokrzycki MM, Weinstein R, Clark P, Balogun RA: Introduction and overview of therapeutic apheresis. J Clin Apher 25:240-249, 2010
14. Norda R, Stegmayr BG, Swedish Apheresis G: Therapeutic apheresis in Sweden: update of epidemiology and adverse events. Transfus Apher Sci 29:159-166, 2003
15. Malchesky PS, Koo AP, Roberson GA, Hadsell AT, Rybicki LA: Apheresis technologies and clinical applications: the 2002 International Apheresis Registry. Ther Apher Dial 8:124-143, 2004
16. Korach JM, Petitpas D, Paris B, Bourgeade F, Passerat V, Berger P, Chillet P, French Registry Group: Plasma exchange in France: epidemiology 2001. Transfus Apher Sci 29:153-157, 2003
17. Rock G, Clark B, Sutton D, CAG, CAAN: The Canadian Apheresis Registry. Transfus Apher Sci 29:167-177, 2003
18. Stegmayr B, Ptak J, Wikstrom B: World Apheresis Registry report. Transfus Apher Sci 36:13-16, 2007
19. Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z: Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial 9:391-395, 2005
20. Shemin D, Briggs D, Greenan M: Complications of therapeutic plasma exchange: a prospective study of 1, 727 procedures. J Clin Apher 22:270-276, 2007
21. Yeo FE, Bohen EM, Yuan CM, Sawyers ES, Abbott KC: Therapeutic plasma exchange as a nephrological procedure: a single center experience. J Clin Apher 20:208-216, 2005
22. Flaum MA, Cuneo RA, Appelbaum FR, Disseroth AB, Engel WK, Gralnick HR: The hemostatic imbalance of plasma exchange transfusion. Blood 54:694-702, 1979
23. Hester JP, McCullough J, Mishler JM, Szymanski IO: Dosage regimens for citrate anticoagulants. J Clin Apher 1:149-157, 1983
24. Olson PR, Cox C, McCullough J: Laboratory and clinical effects of the infusion of ACD solution during platelet-pheresis. Vox Sang 33:79-87, 1977
25. Buskard NA, Varghese Z, Wills MR: Correction of hypocalcemic symptoms during plasma exchange. Lancet 2:344-345, 1976
26. Kaplan AA, Halley SE: Plasma exchange with a rotating filter. Kidney Int 38:160-166, 1990
27. Uhl L, Maillet S, King S, Kruskall MS: Unexpected citrate toxicity and severe hypocalcemia during apheresis. Transfusion 37:1063-1065, 1997
28. Chrinside A, Urbaniak SJ, Prowse CV, Keller AJ: Coagulation abnormalities following intensive plasma exchange on the cell separator. Br J Haematol 48:627-634, 1981
29. Gelabert A, Puig L, Maragall S, Monteagudo J, Castillo R: Coagulation alterations during massive plasmapheresis. Sieverth HG (ed.). Plasma Exchange. Stuttgart, Germany: FK Schattauer Verlag, 1980:71-75
30. Gurland HJ, Lysaght MJ, Samtleben W, Schmidt B: A comparison of centrifugal and membrane based apheresis formats. Int J Artif Organs 7:35-38, 1984
31. Keller AJ, Chirnside A, Urbaniak SJ: Coagulation abnormalities produced by plasma exchange on the cell separator with special reference to fibrinogen and platelet levels. Br J Haematol 42:593-603, 1979
32. Laird JH, Douglas K, Green R: Heparin-induced thrombocytopenia type II: a rare but significant complication of plasma exchange. J Clin Apher 21:129-131, 2006
33. Chopek M, McCullough J: Protein and biochemical changes during plasma exchange. Ulmas J, Berkman E (eds). Therapeutic Hemapheresis: A Technical Workshop. Washington, DC: American Association of Blood Banks, 1980:13-52
34. Wood L, Jacobs P: The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin and complement levels. J Clin Apher 3:124-128, 1986
35. Sultan Y, Bussel A, Maisonneuve P, Sitty X, Gajdos P: Potential danger of thrombosis after plasma exchange in the treatment of patients with immune disease. Transfusion 19:588-593, 1979
36. Aufeuvre JP, Mortin-Hertel F, Cohen-Solal M, Lefloch A, Baudelot J: Clinical tolerance and hazards of plasma exchanges: a study of 6200 plasma exchanges in 1033 patients. Beyer JH, Burgerg H, Fuchs C, Nagel GA (eds). Plasmapheresis in Immunology and Oncology. Basel, Switzerland: Karger, 1982:65-77
37. Kaplan AA: Therapeutic plasma exchange: Core Curriculum 2008. Am J Kidney Dis 52:1180-1196, 2008
38. Keller AJ, Urbaniak SJ: Intensive plasma exchange on the cell separator. Effects on serum immunoglobulins and complement components. Br J Haematol 38:531-540, 1978
39. Kaplan AA: Towards a rational prescription of plasma exchange: the kinetics of immunoglobulin removal (editorial). Semin Dial 5:227-229, 1992
40. Wing EJ, Bruns FJ, Fraley DS, Segel DP, Adler S: Infectious complications with plasmapheresis in rapidly progressively glomerulonephritis. JAMA 244:2423-2426, 1980
41. Lockwood CM, Pinching AJ, Sweny PM, Rees AJ, Pussell B, Uff J, Peters DK: Plasma exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet 1:63-67, 1977
42. Rossen RD, Hersh EM, Sharp JT, McCredie KB, Gyorkey F, Suki WN, Eknoyan G, Reisberg MA: Effect of plasma exchange on circulating immune complexes and antibody formation in patients treated with cyclophosphamide and prednisone. Am J Med 63:674-682, 1977
43. Lockwood CM, Pearson TA, Rees AJ, Evans DJ, Peters DK, Wilson CB: Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet 1:711-715, 1976
44. Johnson JP, Whitman W, Briggs WA, Wilson CB: Plasmapheresis and immunosuppressive agents in antibasement membrane antibody-induced Goodpasture's syndrome. Am J Med 64:354-359, 1978
45. Depner TA, Chafin ME, Wilson CB, Gulyassy PF: Plasmapheresis for severe Goodpasture's syndrome (abstract). Kidney Int 8:409, 1976
46. Lang CH, Brown DC, Staley N, Johnson G, Ma KQ, Border WA, Dalmasso AP: Goodpasture's syndrome treated with immunosuppression and plasma exchange. Arch Intern Med 137:1076-1078, 1977
47. Rosenblatt SG, Knight W, Bannayan GA, Wilson CB, Stein JH: Treatment of Goodpasture's syndrome with plasmapheresis. Am J Med 66:689-696, 1979
48. Walker RG, DApice AJF, Becker GJ, Kincaid-Smith P, Craswell PW: Plasmapheresis in Goodpasture's syndrome with renal failure. Med J Aust 1:875-879, 1979
49. McKenzie PE, Taylor AE, Woodroffe AJ, Seymour AE, Chan YL, Clarkson AR: Plasmapheresis in glomerulonephritis. Clin Nephrol 12:97-108, 1979
50. Pinching AJ, Peters DK, Davis JN: Remission of myasthenia gravis following plasma-exchange. Lancet 2:1373-1376, 1976
51. Dau PC, Lindstrom JM, Cassel CK, Denys EH, Shev EE, Spitter LE: Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 297:1134-1140, 1977
52. Behan PO, Shakir RA, Simpson JA, Burnett AK, Allan TL, Haase G: Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis. Lancet 2:438-440, 1979
53. Newsom-Davis J, Wilson SG, Vincent A, Ward CD: Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet 1:464-468, 1979
54. Winklestein A, Volkin RL, Starz TW, Maxwell NG, Spero JA: The effects of plasma exchange on immunologic factors (abstract). Clin Res 27:691, 1979
55. Pohl MA, Lan SP, Berl T, the Lupus Nephritis Collaborative Study Group: Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. Ann Intern Med 114:924-929, 1991
56. Consensus on IVIG. Lancet 1:470-472, 1990
57. Haas A: Use of intravenous immunoglobulin in immunoregulatory disorders in Stiehm ER, moderator, intravenous immunoglobulins as therapeutic agents. Ann Intern Med 107:367-382, 1987
58. Finlayson JS: Albumin products. Semin Thromb Hemost 6:85-120, 1980
59. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T: Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 331:1607-1611, 1994
60. Schiff RI: Transmission of viral infections through intravenous immune globulin (editorial). N Engl J Med 331:1649-1650, 1994
61. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Gaglioti S, Wright DJ, Dodd RY, Rusch MP, for the National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group: Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 351:760-768, 2004
62. Stramer SL: Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 31:702-707, 2007
63. Dwyre DM, Fernando LP, Holland PV: Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang 100:92-98, 2011
64. Ring J, Messmer K: Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1:466-469, 1977
65. Bambauer R, Jutzler GA, Albrecht D, Keller HE, Kohler M: Indications of plasmapheresis and selection of different substitution solutions. Biomater Artif Cells Artif Organs 17:9-27, 1989
66. Huestis DW: Mortality in therapeutic haemapheresis (letter). Lancet 1:1043, 1983
67. Wallis JP: Transfusion-related acute lung injury (TRALI) under-diagnosed and under-reported (Ed). Br J Anaesth 90:573-576, 2003
68. Stafford CT, Lobel SA, Fruge BC, Moffitt JE, Hoff RG, Fadel HE: Anaphylaxis to human serum albumin. Ann Allergy 61:85-88, 1988
69. Brecher ME, Owen HG, Collins ML: Apheresis and ACE inhibitors (letter). Transfusion 33:963-964, 1993
70. Owen HG, Brecher ME: Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis. Transfusion 34:891-894, 1994
71. Apter AJ, Kaplan AA: An approach to immunologic reactions with plasma exchange. J Allergy Clin Immunol 90:119-124, 1992
72. Olbricht CJ, Schauman D, Fisher D: Anaphylactoid reactions, LDL apheresis with dextran sulphate and ACE inhibitors. Lancet 340:908-909, 1992
73. Kroon AA, Mol MJTM, Stalenhoff APH: ACE inhibitors and LDL-apheresis with dextran sulphate adsorption. Lancet 340:1476, 1992
74. Orlin JB, Berkman EM: Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents. Blood 56:1055-1059, 1980
75. Morrison G, Michelson EL, Brown S, Morganroth J: Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 17:811-819, 1980
76. Pearl RG, Rosenthal MH: Metabolic alkalosis due to plasmapheresis. Am J Med 79:391-393, 1985
77. Mousson C, Charhon SA, Ammar M, Accominotti M, Rifle G: Aluminum bone deposits in normal renal function patients after long-term treatment by plasma exchange. Int J Artif Organs 23:664-667, 1989
78. Milliner DS, Shinaberger JH, Shurman P, Coburn JW: Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin replacement solutions. N Engl J Med 312:165-167, 1985
79. Reddi A, Frank O, DeAngelis B, Jain R, Bashruddin I, Lasker N, Baker H: Vitamin status in patients undergoing single or multiple plasmapheresis. J Am Coll Nutr 6:485-489, 1987
80. MacDonald R, Robinson A: Suxamethonium apnea associated with plasmapheresis. Anaesthesia 35:198-201, 1980
81. Wood GJ, Hall GM: Plasmapheresis and plasma cholinesterase. Br J Anaesth 50:945-948, 1978
82. Bowen RA: Anaesthesia in operations for the relief of hypertension. Anaesthesia 15:3-10, 1960
83. McCaul K, Robinson GD: Suxamethonium extension by tetrahydroaminoacrine. Br J Anaesth 34:536-542, 1962
84. Jorstad S: Biocompatibility of different hemodialysis and plasmapheresis membranes. Blood Purif 5:123-137, 1987
85. Nicholls AJ, Platts MM: Anaphylactoid reactions due to haemodialysis, haemofiltration or membrane plasma separation. BMJ 285:1607-1609, 1982
86. Aeschbacher B, Haeverli A, Nydegger UE: Donor safety and plasma quality in automated plasmapheresis. Vox Sang 57:104-111, 1989